What Is 10-HDA

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 11, 2026

Quick Answer: 10-HDA (10-hydroxy-2-decenoic acid) is a unique unsaturated fatty acid that comprises 1.0–3.9% of royal jelly produced by honeybees. Research demonstrates it extends lifespan through dietary restriction and TOR signaling, while exhibiting potent anti-inflammatory and antioxidant properties that suppress inflammatory mediators like IL-1β and IL-6.

Key Facts

10-HDA makes up 1.0–3.9% of fresh weight royal jelly, making it the major lipid component of this bee secretion
Extends lifespan in laboratory models via dietary restriction and TOR (target of rapamycin) signaling pathways
Suppresses key inflammatory genes including IL-1β, IL-6, MCP-1, and COX-2 with dose-dependent effects
Increases collagen synthesis in human skin fibroblasts, offering protection against UVB-induced photoaging
Scavenges hydroxyl free radicals at rates exceeding 20%, providing cardiovascular and cellular protection

Overview

10-HDA (10-hydroxy-2-decenoic acid) is a unique unsaturated fatty acid with the chemical structure C₁₀H₁₈O₃ that serves as the major lipid component of royal jelly. Produced by worker honeybees as a secretion from their hypopharyngeal glands, royal jelly is a nutrient-dense food reserved exclusively for the queen bee and developing larvae, with 10-HDA concentrations ranging from 1.0 to 3.9 percent of fresh weight.

Beyond its role in supporting bee colony development, 10-HDA has emerged as a significant subject of biomedical research due to its diverse pharmacological properties. Scientists have identified anti-inflammatory, antioxidant, neuroprotective, and anti-aging activities that suggest therapeutic potential for human health. This compound represents one of the most extensively studied components of royal jelly, with multiple peer-reviewed publications documenting its molecular mechanisms and biological effects across different cell and tissue types.

How It Works

10-HDA exerts its biological effects through several interconnected molecular pathways and cellular mechanisms:

TOR Signaling Inhibition: 10-HDA extends lifespan and increases stress resistance by suppressing the mTOR (mammalian target of rapamycin) signaling pathway, which regulates cellular growth and aging processes. This mechanism mimics dietary restriction effects, a well-established longevity intervention.
Anti-inflammatory Action: The compound potently suppresses the expression of major inflammatory mediators including IL-1β, IL-6, MCP-1, and COX-2 genes in a dose-dependent manner. By reducing inflammatory signaling, 10-HDA helps protect tissues from inflammation-related damage and dysfunction.
Antioxidant and Free Radical Scavenging: 10-HDA scavenges hydroxyl free radicals at rates exceeding 20%, protecting cell membranes, proteins, and DNA from oxidative damage. This activity shields vascular smooth muscle cells and other tissues from reactive oxygen species-induced injury.
Gene Regulation and Protein Synthesis: 10-HDA modulates FFAR4 (free fatty acid receptor 4) signaling to inhibit NF-κB pathways, reducing inflammatory and pro-aging gene expression. It also enhances collagen synthesis and growth factor production in skin fibroblasts.
Neuroprotection and Neurogenesis: Research demonstrates that 10-HDA inhibits copper-mediated neuronal pyroptosis (programmed cell death) and promotes neurogenesis of neural stem and progenitor cells, suggesting benefits for brain health and injury recovery.

Key Comparisons

Aspect	10-HDA	Other Royal Jelly Components	Synthetic Compounds
Natural Source	Exclusively from honeybee royal jelly (1–4% concentration)	Proteins, sugars, vitamins also in royal jelly	Synthesized in laboratory; no natural source
Anti-inflammatory Potency	Suppresses IL-1β, IL-6, MCP-1, COX-2 at physiological doses	Proteins (peptides) show modest anti-inflammatory effects	NSAIDs target COX-2 but lack multi-pathway effects of 10-HDA
Lifespan Extension Mechanism	Acts via TOR and dietary restriction pathways	Other components lack proven lifespan-extending effects	Limited options; rapamycin inhibits TOR but with toxicity concerns
Safety Profile	Recognized as safe in royal jelly supplements; no major toxicity reported	Generally recognized as safe (GRAS) status applies to whole jelly	Synthetic drugs often carry side effect profiles requiring monitoring

Why It Matters

Anti-Aging Research: 10-HDA's ability to extend lifespan through TOR inhibition and increase resistance to thermal and oxidative stress positions it as a candidate compound for aging-related interventions, potentially delaying age-related diseases.
Skin Health and Photoaging: By increasing collagen synthesis and transforming growth factor β1 production in human skin fibroblasts, 10-HDA provides protection against UVB-induced photoaging and supports skin elasticity and repair.
Neurological Protection: Its antimicrobial, anti-inflammatory, and antioxidant properties suggest therapeutic potential for traumatic brain injury, neurodegenerative conditions, and cognitive aging through multiple protective mechanisms.
Cardiovascular Defense: 10-HDA scavenges hydroxyl free radicals more effectively than many synthetic antioxidants, protecting vascular tissue from oxidative damage and supporting endothelial function.

10-HDA continues to attract scientific attention as researchers explore its potential in nutraceutical formulations targeting age-related diseases, chronic inflammation, and age-associated cognitive decline. While human clinical trials remain limited, the robust preclinical evidence supports further investigation of 10-HDA as a therapeutic agent. Current royal jelly supplements often advertise 10-HDA content as a marker of quality and potency, reflecting its recognized importance as the primary bioactive component responsible for many of royal jelly's health-promoting effects.